Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases Plaintiffs sought to conduct additional discovery and depositions, as a small group of BioZorb recall lawsuits are being prepared for early trial dates expected to begin in September 2025. February 12, 2025 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all federal BioZorb lawsuits has denied a request by plaintiffs to reopen the discovery and deposition process in a small group of “bellwether” cases previously selected for early trial dates, even thought the manufacturer decided to recall the tissue marker late last year. The BioZorb is a small implant approved for use among breast cancer survivors and other individuals who require targeted radiation therapy, which consists of a biodegradable spacer made from polylactic acid and six permanent titanium clips. Although the implant is designed to gradually break down and dissolve in the body, leaving only the clips in place to aid in the precise marking of previous surgical tumor removal sites, women have been complaining for years about continuing pain, discomfort and other complications that persisted long after receiving the implant, often resulting in the need for the BioZorb marker to be surgically removed. Following years of complaints raised by patients and medical providers, the manufacturer finally agreed to issue a BioZorb marker recall in October 2024, and the FDA recently sent a warning letter outlining manufacturing problems discovered during an inspection of the company’s facility in Massachusetts. However, even prior to the recall, a steadily growing number of product liability lawsuits have been filed against the manufacturer, Hologic, Inc., each raising similar allegations that the company failed to warn about the device failing to dissolve, resulting in injuries and the need for surgical removal. BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in each of the complaints brought in the U.S. District Court for the District of Massachusetts, where the manufacturer’s headquarters are located, the litigation has been centralized before Judge Allison D. Burroughs for coordinated pretrial proceedings and a series of early test trials. Although the outcome of these bellwether trials will not have any binding impact on other claims, they are being closely watched to help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation. The average jury payouts awarded may also have an impact on eventual BioZorb settlement negotiations needed to avoid each individual case going before a jury in the future. Bellwether BioZorb Trials Will Stay on Track After Recall, Warnings In July 2024, Judge Burroughs directed the parties to select a group of 10 BioZorb lawsuits for a “bellwether” process, with each side designating five cases for a Discovery Pool. Those BioZorb injury cases have been going through depositions, exchange of medical records and other case-specific discovery over the past nine months, to help the parties gather information to select a smaller group of cases to present to juries as early test cases. Late last year, the parties whittled that list down to four bellwether trial candidates. Judge Burroughs announced that the first BioZorb lawsuit bellwether trial will begin on September 8, 2025, with a second trial set to begin on January 20, 2026. In a text-only docket entry issued on February 3, Judge Burroughs revealed that some plaintiffs had asked to re-open the discovery process in a motion late last month, calling for new depositions regarding the BioZorb recall, which came after much of the work on prepping the bellwether trials was already completed. However, Judge Burroughs rejected the proposal, indicating she could not see how interviewing plaintiffs’ physicians on a recall that happened months or years afterwards would be relevant to the litigation. “These depositions took place in early 2024,” the judge noted. “Each party agreed to accept the risks and rewards of early discovery, briefing and resolution concerning the learned-intermediary doctrine.” Judge Burroughs indicated that the plaintiffs’ motion was untimely, coming three months after the recall was issued, and after the court has already set a schedule for the bellwether trials. Therefore, the start of the bellwether trials is expected to remain on track, and any additional discovery related to the BioZorb recall and warnings will be limited to future trial selections. Tags: BioZorb, BioZorb Recall, Breast Cancer, Hologic Find Out If You Qualify for BioZorb Failure Compensation More BioZorb Lawsuit Stories Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker March 12, 2025 BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker March 5, 2025 Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court February 21, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: yesterday) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024) Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 2 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025) Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 3 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker March 5, 2025
Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court February 21, 2025
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: yesterday) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024)
Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 2 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 3 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)